Literature DB >> 10889025

Exploring the role of glutamine 50 in the homeodomain-DNA interface: crystal structure of engrailed (Gln50 --> ala) complex at 2.0 A.

R A Grant1, M A Rould, J D Klemm, C O Pabo.   

Abstract

We have determined the crystal structure of a complex containing the engrailed homeodomain Gln50 --> Ala variant (QA50) bound to the wild-type optimal DNA site (TAATTA) at 2.0 A resolution. Biochemical and genetic studies by other groups have suggested that residue 50 is an important determinant of differential DNA-binding specificity among homeodomains (distinguishing among various sites of the general form TAATNN). However, biochemical studies of the QA50 variant had revealed that it binds almost as tightly as the wild-type protein and with only modest changes in specificity. We have now determined the crystal structure of the QA50 variant to help understand the role of residue 50 in site-specific recognition. Our cocrystal structure shows some interesting changes in the water structure at the site of the substitution and shows some changes in the conformations of neighboring side chains. However, the structure, like the QA50 biochemical data, suggests that Gln50 plays a relatively modest role in determining the affinity and specificity of the engrailed homeodomain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10889025     DOI: 10.1021/bi000071a

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  Testing water-mediated DNA recognition by the Hin recombinase.

Authors:  Thang Kien Chiu; Catherine Sohn; Richard E Dickerson; Reid C Johnson
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

2.  Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules.

Authors:  Espen S Baekkevold; Myriam Roussigné; Takeshi Yamanaka; Finn-Eirik Johansen; Frode L Jahnsen; François Amalric; Per Brandtzaeg; Monique Erard; Guttorm Haraldsen; Jean-Philippe Girard
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

3.  A phage display selection of engrailed homeodomain mutants and the importance of residue Q50.

Authors:  Matthew D Simon; Ken Sato; Gregory A Weiss; Kevan M Shokat
Journal:  Nucleic Acids Res       Date:  2004-07-09       Impact factor: 16.971

4.  Dynamic Local Polymorphisms in the Gbx1 Homeodomain Induced by DNA Binding.

Authors:  Andrew Proudfoot; Michael Geralt; Marc-Andre Elsliger; Ian A Wilson; Kurt Wüthrich; Pedro Serrano
Journal:  Structure       Date:  2016-07-07       Impact factor: 5.006

Review 5.  Origins of specificity in protein-DNA recognition.

Authors:  Remo Rohs; Xiangshu Jin; Sean M West; Rohit Joshi; Barry Honig; Richard S Mann
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

6.  A one-dimensional reaction coordinate for identification of transition states from explicit solvent P(fold)-like calculations.

Authors:  David A C Beck; Valerie Daggett
Journal:  Biophys J       Date:  2007-11-15       Impact factor: 4.033

7.  Comparison of multiple crystal structures with NMR data for engrailed homeodomain.

Authors:  Tomasz L Religa
Journal:  J Biomol NMR       Date:  2008-02-15       Impact factor: 2.835

Review 8.  Homeodomain revisited: a lesson from disease-causing mutations.

Authors:  Young-In Chi
Journal:  Hum Genet       Date:  2005-02-23       Impact factor: 4.132

9.  Novel structural features in two ZHX homeodomains derived from a systematic study of single and multiple domains.

Authors:  Louise E Bird; Jingshan Ren; Joanne E Nettleship; Gert E Folkers; Raymond J Owens; David K Stammers
Journal:  BMC Struct Biol       Date:  2010-05-28

10.  Dlx5 Homeodomain:DNA Complex: Structure, Binding and Effect of Mutations Related to Split Hand and Foot Malformation Syndrome.

Authors:  Andrew Proudfoot; Herbert L Axelrod; Michael Geralt; Robert J Fletterick; Fumiaki Yumoto; Ashley M Deacon; Marc-André Elsliger; Ian A Wilson; Kurt Wüthrich; Pedro Serrano
Journal:  J Mol Biol       Date:  2016-01-29       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.